The application of polymer excipients in 3D printing manufacturing is usually limited due to the concerns of filament strength, high processing temperature and large-scale manufacturing. Latest technology developments are targeting a direct melt deposition to simplify the process and enable a constant and efficient process. Two different processing approaches will be presented: The advanced melt drop deposition, where individual three-dimensional geometries can be created by deposition of polymer droplets, and the MED® 3D printing technology which allows precise layer-by-layer deposition to produce objects with well-designed geometric structures.
In this webinar, you will learn:
- Latest advancements of melt-based 3D printing approaches
- Application examples for the individual technologies
- Deep dive in the MED® 3D printing technology to design dedicated drug release profiles
- Excipient requirements for 3D printing technology
Speakers
Thomas Kipping, Ph.D.
MilliporeSigma
Head of 3D Printing & Solubility Enhancement
With more than 12 years of experience in various functions within the pharmaceutical industry, Thomas holds a Ph.D. in pharmaceutical technology and provides a deep understanding of formulation and technology development in the complex area of additive manufacturing and solubility enhancement.
Xianghao Zuo, Ph.D.
Triastek, Inc.
Deputy Director of R&D
Xianghao Zuo received his Ph.D. in materials science and engineering at Stony Brook University. He is now the deputy director of R&D at Triastek, Inc., specializing in developing 3D-printed drug products and improving the solubility and bioavailability of poorly soluble drugs.
Pharma and biopharma manufacturing
- Solid Formulation Strategies
Duration:1h
Language:English
Session 1:presented June 23, 2022
To continue reading please sign in or create an account.
Don't Have An Account?